Related Experiment Video
Updated: Jul 3, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND)
Zhehui Luo1, German F Alvarado, Dorothy K Hatsukami
1Department of Epidemiology, Michigan State University, MI, USA. zluo@rti.org
Abstract:
In a general population sample from the Detroit site of the Collaborative Genetic Study of Nicotine Dependence (COGEND), we tested Black-White differences in nicotine dependence, measured by "how soon after wake-up the smokers smoked their first cigarette (time to first cigarette TTFC)", and its relationship with number of cigarettes per day (CPD). Analysis was conducted on respondents who have smoked > or =100 cigarettes in lifetime and were current smokers (n = 1,442; 1,087 Whites and 355 Blacks). In univariate analysis, we found no significant race differences on time to first cigarette (chi2 = 2.9, p value = 0.41), but significant race differences on CPD (chi2 = 154.3, p<.01), both categorized by the Fagerström Test of Nicotine Dependence (FTND) cutoffs. We estimated the probability of TTFC < or =30 min given CPD using probit models. The interactions between race and CPD indicated significant differences in dependence at various levels of CPD. The same probability of nicotine dependence was associated with smaller increments in CPD for Blacks than for Whites. The data support the hypothesis that the relationship between CPD and nicotine dependence as reflected in relapse varies by race, and that Black smokers are dependent at lower levels of CPD than Whites.
Related Concept Videos
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Incomplete Dominance
